Kessler Topaz is currently investigating claims against AbbVie Inc. for potential violations of state law and/or federal laws. Specifically, Kessler Topaz is investigating whether AbbVie Inc. violated state law and/or federal laws in connection with the significant inflation of Humira’s list price over the past several years. For example, the cost of Humira’s list price doubled in a five-year period alone (from January 2015 to January 2020), however, these inflated price increases lack any reasonable relationship to production costs, the recoupment of research and development costs, or to the cost of other consumer goods. As a result, consumers were forced to pay an unfair and unconscionable price which cannot be avoided unless they don’t take Humira as prescribed.
Please contact us today to discuss your rights if you have taken Humira at any time from 2015 to the present. You may contact us at 484-270-1453, or you can fill out our online form below, or by email at info@ktmc.com.